The product promised to help her burn fat and build muscle, and it was readily available over the counter at health-food stores.
It sounded like the answer to her prayers: a training and diet aid that would help her get fit fast and get back to the business of cracking the top 100 in women's tennis.
Instead, Reeves' decision to use the product backfired badly.
Required to submit a urine sample at an event last December as part of tennis' effort to detect improper drug use, Reeves failed the test.
The dietary product, it turned out, had contained Nor-Andro 19, a variation on the classic steroid nandrolone and one of the substances banned by the sport.
The International Tennis Federation, which governs the sport, ultimately did not suspend or otherwise discipline Reeves, who was ranked No.